« Back
Home /
Tazarotene

Tazarotene

Item no.	M3973-100mg
Manufacturer	AbMole
CASRN	118292-40-3
Amount	100mg
Category	Oncology Inhibitors & Compound Libraries Small Molecules By Organ Skin Cancer
Type	Inhibitors
Specific against	other
Purity	0,999
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	Tazorac; Zorac; AGN 190168
Available
Target Information	RAR/RXR
Molecular Weight	351, 46
Solubility	DMSO >30 mg/mL
Bioactivity information	Tazarotene (AGN 190168) is a new member of the acetylenic class of RARβ/γ selective retinoids which is approved to treat a variety of skin diseases, exhibits an anti-proliferative effect in human basal cell carcinoma (BCC) by triggering caspase-dependent apoptosis.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

M3973-100mg-safety-datasheet.pdf